Form 4 Tracker
Adaptive Biotechnologies Corp
ADPT

42 insider filings · Latest: Apr 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 12, 2025Nov 12 9:58 PMChad Robins
Proposed Sale
1,876$14.50$27.2K

View →

Nov 11, 2025Nov 12 1:09 PMChad Robins
Proposed Sale
1,237$14.53$18.0K

View →

Nov 10, 2025Nov 10 11:48 PMChad Robins
Proposed Sale
86,161$14.71$1.3M

View →

Nov 10, 2025Nov 10 11:48 PMHarlan Robins
Proposed Sale
10,000$14.71$147.1K

View →

May 1, 2025May 1 9:38 PMHarlan Robins
Proposed Sale
68,412$7.36$503.5K

View →

Mar 24, 2025Mar 24 9:45 PMHarlan Robins
Proposed Sale
1,698$8.66$14.7K

View →

Mar 13, 2025Mar 13 9:28 PMGRIFFIN MICHELLE RENEE
Proposed Sale
36,291$7.19$260.9K

View →

Mar 12, 2025Mar 12 9:30 PMHERSHBERG ROBERT
Proposed Sale
53,000$7.59$402.3K

View →

Mar 10, 2025Mar 10 6:48 PMNEUPERT PETER M
Proposed Sale
10,000$7.05$70.5K

View →

Mar 6, 2025Mar 6 9:10 PMMICHELLE GRIFFIN
Proposed Sale
15,664$7.94$124.4K

View →

Feb 20, 2025Feb 20 9:02 PMChad Robins
Proposed Sale
99,107$8.37$829.5K

View →

Feb 19, 2025Feb 19 9:51 PMChad Robins
Proposed Sale
186,080$8.37$1.6M

View →

Feb 18, 2025Feb 18 10:35 PMChad Robins
Proposed Sale
211,160$8.27$1.7M

View →

Feb 14, 2025Feb 14 9:11 PMChad Robins
Proposed Sale
158,921$8.33$1.3M

View →

Feb 13, 2025Feb 13 10:11 PMChad Robins
Proposed Sale
100,287$8.52$854.4K

View →

Aug 22, 2024Aug 22 8:18 PMSTACY L TAYLOR
Proposed Sale
26,922$4.50$121.1K

View →

← Previous

Page 6 of 6

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Option Exercise
2,145$12.142,146(D)

View →

← Previous

Page 3 of 3